Report #2827568

Overview

Sex

Male

Age

Age unknown

State

CA

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Twinrix second dose was administered 6 months later and today patient wants to received the third dose ( 11 months apart).; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a male patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (patient that received Twinrix first dose back in March). On an unknown date, the patient received the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: Twinrix second dose was administered 6 months later and today patient wants to received the third dose ( 11 months apart).). The outcome of the drug dose administration interval too long was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 14-FEB-2025 Other HCP reported that an adult patient that received Twinrix first dose back in March. Twinrix second dose was administered 6 months later, which led to drug dose interval too long and on the day of reporting patient wanted to received the third dose at 11 months apart. Reporter decided to discussed this question with patient's doctor before arriving to an answer.